Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This study will evaluate the efficacy and aafety of rosuvastatin/ezetimibe combination therapy vs. rosuvastatin monotherapy in atherosclerotic cardiovascular disease patients with type 2 diabetes mellitus
Epistemonikos ID: d109f992140f81d06be5e215246b04318e62c72e
First added on: May 21, 2024